0001214659-21-000333.txt : 20210108 0001214659-21-000333.hdr.sgml : 20210108 20210108191509 ACCESSION NUMBER: 0001214659-21-000333 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210107 FILED AS OF DATE: 20210108 DATE AS OF CHANGE: 20210108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Faga Daniel CENTRAL INDEX KEY: 0001673528 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 21518765 MAIL ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-50910.xml PRIMARY DOCUMENT X0306 4 2021-01-07 0001576263 Mirati Therapeutics, Inc. MRTX 0001673528 Faga Daniel C/O MIRATI THERAPEUTICS 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 false true false false EVP, Chief Operating Officer Common Stock 2021-01-07 4 S false 12 215.307 D 26228 D Common Stock 2021-01-07 4 S false 2613 216.33 D 23615 D Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 6, 2020. /s/ Vickie Reed, Attorney-inFact 2021-01-08